暗殺者 asked in 社會與文化語言 · 1 decade ago

醫學期刊 英翻中 謝謝囉!!!

Serum FLC measurement was added to all requests for

SPEP received from primary care or hospital sources from

August 1 to November 30, 2004. Samples from patients

with previous diagnoses of myeloma, Waldenstrom’s

macroglobulinaemia, and lymphoma were excluded.

We measured κ and λserum FLC concentrations

quantitatively by immunoturbidimetry (The Binding Site)

on a Roche modular analyzer (CV for between batch

precision: = 8%, =3%).

When concurrent urine samples were available,

urine total protein was measured (benzethonium chloride,

Roche modular analyzer, or 917 analyzer) followed

by UPEP (Sebia Hydragel 1-2 15/30 gels, HR3 program

and acid violet stain); unconcentrated urine was used on

the basis of recent recommendations.

不了解內容,請幫幫我!!!

2 Answers

Rating
  • 1 decade ago
    Favorite Answer

    血清游離輕鏈檢查加入所有從主要的醫護機構所及醫院所收集的血清蛋白電泳(serum protein electrophoresis; SPEP)檢驗中(收集時間為2004年八月一日至十一月三十日)所採集的樣本中排除了被診斷有"威爾登史壯大球血液蛋白病" 與淋巴瘤的病人.

    我們藉由在Roche模件分析器上的免疫濁度計檢測了k與λ血清游離輕鏈濃度(cv? 介於批準度=8%, =3%)

    尿液樣本中測出總體蛋白(氯化苯銨松寧,Roche模件分析器或917分析器), 緊接著尿液蛋白電泳檢驗upep(urine protein electrophoresis)Sebia 電泳套組膠片1-2 15/30, HR3程式與紫色酸性染色); 未濃縮的尿液則適用於最近的建康建議

    • Login to reply the answers
  • 1 decade ago

    血清FLC 測量被增加到所有人要求

    SPEP從從最初保健護理或者醫院源收到

    8月1日到2004年11月30日。 來自病患的樣品

    用骨髓瘤,Waldenstrom的以前的診斷

    macroglobulinaemia,和淋巴腺癌被排除。

    我們測量 κ 並且 λ血清FLC 集中

    量透過immunoturbidimetry(捆的場所)

    在某位羅奇上標準化分析器(在批之間的CV

    精密︰ =8%,= 3%) .

    當一致的尿樣品是可提供的時,

    尿總蛋白質是被測量的(benzethonium 氯化物,

    羅奇標準化的分析器或者917 分析器) 跟隨

    以UPEP(1-2 15/30 凝膠的Sebia Hydragel,HR3 計畫

    以及酸紫色的污點) ; unconcentrated尿被使用在上

    新近的建議的基礎。

    Source(s): 電腦
    • Login to reply the answers
Still have questions? Get your answers by asking now.